|
TScan Therapeutics, Inc.
Ticker Symbol: TCRX CUSIP: 89854M101 Exchange: NGM
Company's Online Profile
BUSINESS: TScan Therapeutics, Inc. is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer.
|
IPO - 7/16/2021 - 6.67 Million Shares @ $15.00/share.
Link to IPO Prospectus
Small Cap Stock -
Market Value $ Million
Click for current TCRX price quote from the NASDAQ
Company's Online Information Links
|
Company's Online SEC EDGAR Filings |
Company's Email Address Links |
Address and Phone Numbers |
Address: 830 Winter Street, Waltham, MA 02451 |
Main Phone Number |
857-339-9500 |
Fax Number |
Not Available |
Investor Contact
Heather Savelle
|
857-399-9840
|
CEO - Gavin MacBeath |
CFO - Brian M. Silver |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|